Berachain's Refund Policy Balances Safeguarding Investors With Ensuring Project Longevity
- Berachain co-founder denies claims of a $25M refund clause in its Series B funding, calling reports "inaccurate and incomplete." - The clause allows Nova Digital to reclaim its $25M investment until February 2026, triggering legal criticism for its "highly unusual" post-TGE refund terms. - Legal experts warn the clause may violate MFN rights, as undisclosed terms could disadvantage other investors while shielding Nova from downside risk. - The $100M Series B deal at $1.5B valuation has intensified debate
Berachain's co-founder has labeled reports about a $25 million refund clause linked to its Series B funding as "misleading and lacking context," as scrutiny mounts over the layer-1 blockchain's financing arrangements. The debate focuses on a provision allowing Brevan Howard's Nova Digital fund to reclaim its full investment up until February 6, 2026, which is one year after Berachain's token generation event (TGE).
This clause has faced significant pushback from legal professionals, who characterize such post-TGE refund provisions as "extremely rare" in token fundraising deals.
The agreement's terms may also present legal challenges.
The Series B funding round, which was co-led by Framework Ventures and Nova Digital,
Brevan Howard Digital and Nova co-founder Ashwin Ramachandran chose not to respond
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silicon Valley's surge in baby technology faces challenges related to affordability, ethical concerns, and unequal access
- Silicon Valley's AI-driven biotech sector is accelerating growth in the U.S. artificial insemination market, projected to expand from $0.76B to $1.41B by 2033. - Financial barriers persist as limited insurance coverage forces patients to pay full treatment costs, hindering market accessibility according to 2025 analysis. - Tech giants like Synopsys and ABVC BioPharma are advancing AI tools and domestic pharmaceutical development to optimize reproductive technologies and supply chains. - Fertility clinics

Transferring Cryptocurrency Assets into Conventional Home Loans: Australia’s Pioneering Unified Solution
- Australia's first crypto-focused mortgage service, Mortgage On Chain, partners with Tax On Chain to provide integrated mortgage and tax advice for digital-asset holders. - The service helps investors secure traditional home loans by managing crypto portfolios and tax obligations without offering crypto-backed lending products. - It addresses gaps in traditional lending criteria for younger crypto investors while aligning mortgage applications with standard banking requirements and tax frameworks. - The c

Opportunities for Revitalizing Post-Industrial Sites: A Strategic Perspective on Webster, NY
- Webster , NY, is transforming a 300-acre brownfield into a high-tech industrial hub via a $9.8M FAST NY grant, boosting advanced manufacturing and logistics. - Projects like the $650M fairlife® dairy facility and Xerox Campus redevelopment highlight strategic focus on job creation and mixed-use development, supported by tax incentives and infrastructure upgrades. - Proximity to Buffalo’s port, 2% industrial vacancy rates, and ESG-aligned remediation efforts position Webster as a logistics and real estate

ICP Price Jumps 30% in a Week: What Factors Are Fueling the Crypto Market’s Latest Spotlight?
- ICP surged 30% in November 2025 driven by technical breakouts, institutional partnerships, and AI innovation like the Caffeine platform. - Strategic collaborations with tech giants and $237B TVL growth signaled growing adoption for enterprise blockchain solutions. - A $4.20-$4.31 price breakout with 261% volume spike highlighted short-term momentum despite lack of major on-chain upgrades. - Long-term viability remains uncertain due to limited adoption metrics and reliance on speculative inflows amid macr
